Valuation: Boston Scientific Corporation

Market Cap 63.26B 55.71B 52.78B 47.65B 89.81B 6,065B 90.97B 631B 243B 3,101B 238B 232B 9,941B P/E 2026 *
16.5x
P/E 2027 * 17.3x
Enterprise Value 71.99B 63.39B 60.06B 54.22B 102B 6,902B 104B 719B 277B 3,529B 270B 264B 11,313B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.09x
Free-Float
82.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 01/11/2011
Director of Finance/CFO 52 30/06/2025
Chief Tech/Sci/R&D Officer - 01/09/2009
Director TitleAgeSince
Chairman 61 03/05/2016
Director/Board Member 74 01/03/2014
Director/Board Member 74 15/04/2016
Change 5-day change 1-year change 3-year change Capi.($)
+20.39%-.--% - - 63.26B
-0.67%+1.47%+39.18%+33.36% 250B
-2.02%-0.00%+11.75%-10.70% 156B
-1.35%+2.09%-9.08%+39.12% 144B
-0.52%-2.17%-55.29%-17.33% 63.26B
-2.00%-0.58%+10.99%+24.60% 49.75B
-1.55%+4.23%+34.25%+54.10% 48.58B
-0.20%+2.07%-17.49%-20.90% 47.99B
+2.47%+5.43%-4.18%+40.30% 46.22B
-0.87%+4.47%+46.56%+60.24% 43.17B
Average +1.37%+2.27%+6.30%+22.53% 94.22B
Weighted average by Cap. +0.54%+2.37%+11.79%+21.81%

Financials

2026 *2027 *
Net sales 21.25B 18.71B 17.73B 16.01B 30.17B 2,038B 30.56B 212B 81.63B 1,042B 79.79B 78.05B 3,339B 22.24B 19.58B 18.56B 16.75B 31.57B 2,132B 31.98B 222B 85.43B 1,090B 83.51B 81.69B 3,495B
Net income 3.79B 3.34B 3.16B 2.85B 5.38B 363B 5.45B 37.81B 14.55B 186B 14.22B 13.91B 595B 3.67B 3.23B 3.06B 2.76B 5.21B 352B 5.28B 36.63B 14.1B 180B 13.78B 13.48B 577B
Net Debt 8.73B 7.69B 7.28B 6.57B 12.39B 837B 12.55B 87.13B 33.53B 428B 32.77B 32.06B 1,372B 5.49B 4.84B 4.58B 4.14B 7.8B 527B 7.9B 54.85B 21.11B 269B 20.63B 20.18B 864B
Logo Boston Scientific Corporation
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows: - cardiovascular (66%): products used in cardiology surgeries (35% of net sales), electrophysiology tests (25.1%) cardiac rhythm management (17.6%), peripheral surgeries (7.5%), and other (14.8%); - endodontic surgery (28%): equipment used in endoscopy (51.8% of net sales), and urology (48.2%) ; - neuromodulation (6%). Net sales are distributed geographically as follows: the United States (64.1%), Europe/Middle East/Africa (17.2%), Asia/Pacific (15.4%) and other (3.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
43.65USD
Average target price
61.00USD
Spread / Average Target
+39.75%

Quarterly revenue - Rate of surprise